You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

~ Buy the VIBATIV (telavancin hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR VIBATIV

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VIBATIV

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00061633 ↗	Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)	Completed	Cumberland Pharmaceuticals	Phase 2	2003-06-01	Serious infections caused by resistant bacteria are becoming more of a medical problem throughout the world. One of the ways to deal with this problem is to develop new drugs that can control these bacteria. This study will measure how well TD-6424 (Telavancin) can control infections and whether this drug can be safely given to patients.
NCT00061633 ↗	Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)	Completed	Theravance Biopharma Antibiotics, Inc.	Phase 2	2003-06-01	Serious infections caused by resistant bacteria are becoming more of a medical problem throughout the world. One of the ways to deal with this problem is to develop new drugs that can control these bacteria. This study will measure how well TD-6424 (Telavancin) can control infections and whether this drug can be safely given to patients.
NCT00062647 ↗	Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia	Completed	Cumberland Pharmaceuticals	Phase 2	2003-08-01	The purpose of this study is to determine whether telavancin (TD-6424, ARBELIC) can be safety administered to patients with bloodstream infections and whether telavancin is effective in treating these infections.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VIBATIV

Condition Name

Chart
Table

Condition Name for VIBATIV
Intervention	Trials
Gram-Positive Bacterial Infections	2
Infections, Gram-Positive Bacterial	2
Bacterial Pneumonia	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VIBATIV
Intervention	Trials
Infection	5
Communicable Diseases	5
Infections	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VIBATIV

Trials by Country

Map
Table

Trials by Country for VIBATIV
Location	Trials
United States	17
Israel	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VIBATIV
Location	Trials
California	5
Louisiana	1
Massachusetts	1
Georgia	1
Kentucky	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VIBATIV

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VIBATIV
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	4
Phase 2	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VIBATIV
Clinical Trial Phase	Trials
Completed	11
Recruiting	2
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VIBATIV

Sponsor Name

Chart
Table

Sponsor Name for VIBATIV
Sponsor	Trials
Theravance Biopharma Antibiotics, Inc.	12
Cumberland Pharmaceuticals	10
Theravance Biopharma	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VIBATIV
Sponsor	Trials
Industry	26
Other	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.